Global Live Attenuated Japanese Encephalitis Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Live Attenuated Japanese Encephalitis Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Epidemic Japanese encephalitis (hereinafter referred to as 'JE') is an acute infectious disease of the central nervous system caused by the Japanese encephalitis virus, with inflammation of the brain parenchyma as the main lesion.
This report is a detailed and comprehensive analysis for global Live Attenuated Japanese Encephalitis Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Live Attenuated Japanese Encephalitis Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Live Attenuated Japanese Encephalitis Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Live Attenuated Japanese Encephalitis Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Live Attenuated Japanese Encephalitis Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Live Attenuated Japanese Encephalitis Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Live Attenuated Japanese Encephalitis Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Sanofi, Chengdu Institute of Biological Products, Wuhan Institute of Biological Products and Lanzhou Institute of Biological Products, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Live Attenuated Japanese Encephalitis Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Live Attenuated Japanese Encephalitis Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Live Attenuated Japanese Encephalitis Vaccine, with price, sales, revenue and global market share of Live Attenuated Japanese Encephalitis Vaccine from 2018 to 2023.
Chapter 3, the Live Attenuated Japanese Encephalitis Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Live Attenuated Japanese Encephalitis Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Live Attenuated Japanese Encephalitis Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Live Attenuated Japanese Encephalitis Vaccine.
Chapter 14 and 15, to describe Live Attenuated Japanese Encephalitis Vaccine sales channel, distributors, customers, research findings and conclusion.
Epidemic Japanese encephalitis (hereinafter referred to as 'JE') is an acute infectious disease of the central nervous system caused by the Japanese encephalitis virus, with inflammation of the brain parenchyma as the main lesion.
This report is a detailed and comprehensive analysis for global Live Attenuated Japanese Encephalitis Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Live Attenuated Japanese Encephalitis Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Live Attenuated Japanese Encephalitis Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Live Attenuated Japanese Encephalitis Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Live Attenuated Japanese Encephalitis Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Live Attenuated Japanese Encephalitis Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Live Attenuated Japanese Encephalitis Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Sanofi, Chengdu Institute of Biological Products, Wuhan Institute of Biological Products and Lanzhou Institute of Biological Products, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Live Attenuated Japanese Encephalitis Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- 0.5ml
- 1ml
- 2.5ml
- Hospital
- Clinic
- Novartis
- Sanofi
- Chengdu Institute of Biological Products
- Wuhan Institute of Biological Products
- Lanzhou Institute of Biological Products
- Beijing Temple of Heaven Biological Products
- Valneva
- Bharat Biotech
- Cheng Da Biology
- Biocelect Pty Ltd
- Glovax Co., Ltd.
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Live Attenuated Japanese Encephalitis Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Live Attenuated Japanese Encephalitis Vaccine, with price, sales, revenue and global market share of Live Attenuated Japanese Encephalitis Vaccine from 2018 to 2023.
Chapter 3, the Live Attenuated Japanese Encephalitis Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Live Attenuated Japanese Encephalitis Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Live Attenuated Japanese Encephalitis Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Live Attenuated Japanese Encephalitis Vaccine.
Chapter 14 and 15, to describe Live Attenuated Japanese Encephalitis Vaccine sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Live Attenuated Japanese Encephalitis Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 0.5ml
1.3.3 1ml
1.3.4 2.5ml
1.4 Market Analysis by Application
1.4.1 Overview: Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.5 Global Live Attenuated Japanese Encephalitis Vaccine Market Size & Forecast
1.5.1 Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity (2018-2029)
1.5.3 Global Live Attenuated Japanese Encephalitis Vaccine Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Live Attenuated Japanese Encephalitis Vaccine Product and Services
2.1.4 Novartis Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Novartis Recent Developments/Updates
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Live Attenuated Japanese Encephalitis Vaccine Product and Services
2.2.4 Sanofi Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Sanofi Recent Developments/Updates
2.3 Chengdu Institute of Biological Products
2.3.1 Chengdu Institute of Biological Products Details
2.3.2 Chengdu Institute of Biological Products Major Business
2.3.3 Chengdu Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product and Services
2.3.4 Chengdu Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Chengdu Institute of Biological Products Recent Developments/Updates
2.4 Wuhan Institute of Biological Products
2.4.1 Wuhan Institute of Biological Products Details
2.4.2 Wuhan Institute of Biological Products Major Business
2.4.3 Wuhan Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product and Services
2.4.4 Wuhan Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Wuhan Institute of Biological Products Recent Developments/Updates
2.5 Lanzhou Institute of Biological Products
2.5.1 Lanzhou Institute of Biological Products Details
2.5.2 Lanzhou Institute of Biological Products Major Business
2.5.3 Lanzhou Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product and Services
2.5.4 Lanzhou Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Lanzhou Institute of Biological Products Recent Developments/Updates
2.6 Beijing Temple of Heaven Biological Products
2.6.1 Beijing Temple of Heaven Biological Products Details
2.6.2 Beijing Temple of Heaven Biological Products Major Business
2.6.3 Beijing Temple of Heaven Biological Products Live Attenuated Japanese Encephalitis Vaccine Product and Services
2.6.4 Beijing Temple of Heaven Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Beijing Temple of Heaven Biological Products Recent Developments/Updates
2.7 Valneva
2.7.1 Valneva Details
2.7.2 Valneva Major Business
2.7.3 Valneva Live Attenuated Japanese Encephalitis Vaccine Product and Services
2.7.4 Valneva Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Valneva Recent Developments/Updates
2.8 Bharat Biotech
2.8.1 Bharat Biotech Details
2.8.2 Bharat Biotech Major Business
2.8.3 Bharat Biotech Live Attenuated Japanese Encephalitis Vaccine Product and Services
2.8.4 Bharat Biotech Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Bharat Biotech Recent Developments/Updates
2.9 Cheng Da Biology
2.9.1 Cheng Da Biology Details
2.9.2 Cheng Da Biology Major Business
2.9.3 Cheng Da Biology Live Attenuated Japanese Encephalitis Vaccine Product and Services
2.9.4 Cheng Da Biology Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Cheng Da Biology Recent Developments/Updates
2.10 Biocelect Pty Ltd
2.10.1 Biocelect Pty Ltd Details
2.10.2 Biocelect Pty Ltd Major Business
2.10.3 Biocelect Pty Ltd Live Attenuated Japanese Encephalitis Vaccine Product and Services
2.10.4 Biocelect Pty Ltd Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Biocelect Pty Ltd Recent Developments/Updates
2.11 Glovax Co., Ltd.
2.11.1 Glovax Co., Ltd. Details
2.11.2 Glovax Co., Ltd. Major Business
2.11.3 Glovax Co., Ltd. Live Attenuated Japanese Encephalitis Vaccine Product and Services
2.11.4 Glovax Co., Ltd. Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Glovax Co., Ltd. Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: LIVE ATTENUATED JAPANESE ENCEPHALITIS VACCINE BY MANUFACTURER
3.1 Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Live Attenuated Japanese Encephalitis Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Live Attenuated Japanese Encephalitis Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Live Attenuated Japanese Encephalitis Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Live Attenuated Japanese Encephalitis Vaccine Manufacturer Market Share in 2022
3.5 Live Attenuated Japanese Encephalitis Vaccine Market: Overall Company Footprint Analysis
3.5.1 Live Attenuated Japanese Encephalitis Vaccine Market: Region Footprint
3.5.2 Live Attenuated Japanese Encephalitis Vaccine Market: Company Product Type Footprint
3.5.3 Live Attenuated Japanese Encephalitis Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Live Attenuated Japanese Encephalitis Vaccine Market Size by Region
4.1.1 Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Live Attenuated Japanese Encephalitis Vaccine Average Price by Region (2018-2029)
4.2 North America Live Attenuated Japanese Encephalitis Vaccine Consumption Value (2018-2029)
4.3 Europe Live Attenuated Japanese Encephalitis Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Consumption Value (2018-2029)
4.5 South America Live Attenuated Japanese Encephalitis Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Live Attenuated Japanese Encephalitis Vaccine Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Type (2018-2029)
5.3 Global Live Attenuated Japanese Encephalitis Vaccine Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Application (2018-2029)
6.3 Global Live Attenuated Japanese Encephalitis Vaccine Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Live Attenuated Japanese Encephalitis Vaccine Market Size by Country
7.3.1 North America Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Live Attenuated Japanese Encephalitis Vaccine Market Size by Country
8.3.1 Europe Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Market Size by Region
9.3.1 Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Live Attenuated Japanese Encephalitis Vaccine Market Size by Country
10.3.1 South America Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Market Size by Country
11.3.1 Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Live Attenuated Japanese Encephalitis Vaccine Market Drivers
12.2 Live Attenuated Japanese Encephalitis Vaccine Market Restraints
12.3 Live Attenuated Japanese Encephalitis Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Live Attenuated Japanese Encephalitis Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Live Attenuated Japanese Encephalitis Vaccine
13.3 Live Attenuated Japanese Encephalitis Vaccine Production Process
13.4 Live Attenuated Japanese Encephalitis Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Live Attenuated Japanese Encephalitis Vaccine Typical Distributors
14.3 Live Attenuated Japanese Encephalitis Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Live Attenuated Japanese Encephalitis Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 0.5ml
1.3.3 1ml
1.3.4 2.5ml
1.4 Market Analysis by Application
1.4.1 Overview: Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.5 Global Live Attenuated Japanese Encephalitis Vaccine Market Size & Forecast
1.5.1 Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity (2018-2029)
1.5.3 Global Live Attenuated Japanese Encephalitis Vaccine Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Live Attenuated Japanese Encephalitis Vaccine Product and Services
2.1.4 Novartis Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Novartis Recent Developments/Updates
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Live Attenuated Japanese Encephalitis Vaccine Product and Services
2.2.4 Sanofi Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Sanofi Recent Developments/Updates
2.3 Chengdu Institute of Biological Products
2.3.1 Chengdu Institute of Biological Products Details
2.3.2 Chengdu Institute of Biological Products Major Business
2.3.3 Chengdu Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product and Services
2.3.4 Chengdu Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Chengdu Institute of Biological Products Recent Developments/Updates
2.4 Wuhan Institute of Biological Products
2.4.1 Wuhan Institute of Biological Products Details
2.4.2 Wuhan Institute of Biological Products Major Business
2.4.3 Wuhan Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product and Services
2.4.4 Wuhan Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Wuhan Institute of Biological Products Recent Developments/Updates
2.5 Lanzhou Institute of Biological Products
2.5.1 Lanzhou Institute of Biological Products Details
2.5.2 Lanzhou Institute of Biological Products Major Business
2.5.3 Lanzhou Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product and Services
2.5.4 Lanzhou Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Lanzhou Institute of Biological Products Recent Developments/Updates
2.6 Beijing Temple of Heaven Biological Products
2.6.1 Beijing Temple of Heaven Biological Products Details
2.6.2 Beijing Temple of Heaven Biological Products Major Business
2.6.3 Beijing Temple of Heaven Biological Products Live Attenuated Japanese Encephalitis Vaccine Product and Services
2.6.4 Beijing Temple of Heaven Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Beijing Temple of Heaven Biological Products Recent Developments/Updates
2.7 Valneva
2.7.1 Valneva Details
2.7.2 Valneva Major Business
2.7.3 Valneva Live Attenuated Japanese Encephalitis Vaccine Product and Services
2.7.4 Valneva Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Valneva Recent Developments/Updates
2.8 Bharat Biotech
2.8.1 Bharat Biotech Details
2.8.2 Bharat Biotech Major Business
2.8.3 Bharat Biotech Live Attenuated Japanese Encephalitis Vaccine Product and Services
2.8.4 Bharat Biotech Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Bharat Biotech Recent Developments/Updates
2.9 Cheng Da Biology
2.9.1 Cheng Da Biology Details
2.9.2 Cheng Da Biology Major Business
2.9.3 Cheng Da Biology Live Attenuated Japanese Encephalitis Vaccine Product and Services
2.9.4 Cheng Da Biology Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Cheng Da Biology Recent Developments/Updates
2.10 Biocelect Pty Ltd
2.10.1 Biocelect Pty Ltd Details
2.10.2 Biocelect Pty Ltd Major Business
2.10.3 Biocelect Pty Ltd Live Attenuated Japanese Encephalitis Vaccine Product and Services
2.10.4 Biocelect Pty Ltd Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Biocelect Pty Ltd Recent Developments/Updates
2.11 Glovax Co., Ltd.
2.11.1 Glovax Co., Ltd. Details
2.11.2 Glovax Co., Ltd. Major Business
2.11.3 Glovax Co., Ltd. Live Attenuated Japanese Encephalitis Vaccine Product and Services
2.11.4 Glovax Co., Ltd. Live Attenuated Japanese Encephalitis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Glovax Co., Ltd. Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: LIVE ATTENUATED JAPANESE ENCEPHALITIS VACCINE BY MANUFACTURER
3.1 Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Live Attenuated Japanese Encephalitis Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Live Attenuated Japanese Encephalitis Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Live Attenuated Japanese Encephalitis Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Live Attenuated Japanese Encephalitis Vaccine Manufacturer Market Share in 2022
3.5 Live Attenuated Japanese Encephalitis Vaccine Market: Overall Company Footprint Analysis
3.5.1 Live Attenuated Japanese Encephalitis Vaccine Market: Region Footprint
3.5.2 Live Attenuated Japanese Encephalitis Vaccine Market: Company Product Type Footprint
3.5.3 Live Attenuated Japanese Encephalitis Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Live Attenuated Japanese Encephalitis Vaccine Market Size by Region
4.1.1 Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Live Attenuated Japanese Encephalitis Vaccine Average Price by Region (2018-2029)
4.2 North America Live Attenuated Japanese Encephalitis Vaccine Consumption Value (2018-2029)
4.3 Europe Live Attenuated Japanese Encephalitis Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Consumption Value (2018-2029)
4.5 South America Live Attenuated Japanese Encephalitis Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Live Attenuated Japanese Encephalitis Vaccine Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Type (2018-2029)
5.3 Global Live Attenuated Japanese Encephalitis Vaccine Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Application (2018-2029)
6.3 Global Live Attenuated Japanese Encephalitis Vaccine Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Live Attenuated Japanese Encephalitis Vaccine Market Size by Country
7.3.1 North America Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Live Attenuated Japanese Encephalitis Vaccine Market Size by Country
8.3.1 Europe Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Market Size by Region
9.3.1 Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Live Attenuated Japanese Encephalitis Vaccine Market Size by Country
10.3.1 South America Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Market Size by Country
11.3.1 Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Live Attenuated Japanese Encephalitis Vaccine Market Drivers
12.2 Live Attenuated Japanese Encephalitis Vaccine Market Restraints
12.3 Live Attenuated Japanese Encephalitis Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Live Attenuated Japanese Encephalitis Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Live Attenuated Japanese Encephalitis Vaccine
13.3 Live Attenuated Japanese Encephalitis Vaccine Production Process
13.4 Live Attenuated Japanese Encephalitis Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Live Attenuated Japanese Encephalitis Vaccine Typical Distributors
14.3 Live Attenuated Japanese Encephalitis Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Novartis Basic Information, Manufacturing Base and Competitors
Table 4. Novartis Major Business
Table 5. Novartis Live Attenuated Japanese Encephalitis Vaccine Product and Services
Table 6. Novartis Live Attenuated Japanese Encephalitis Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Novartis Recent Developments/Updates
Table 8. Sanofi Basic Information, Manufacturing Base and Competitors
Table 9. Sanofi Major Business
Table 10. Sanofi Live Attenuated Japanese Encephalitis Vaccine Product and Services
Table 11. Sanofi Live Attenuated Japanese Encephalitis Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Sanofi Recent Developments/Updates
Table 13. Chengdu Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 14. Chengdu Institute of Biological Products Major Business
Table 15. Chengdu Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product and Services
Table 16. Chengdu Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Chengdu Institute of Biological Products Recent Developments/Updates
Table 18. Wuhan Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 19. Wuhan Institute of Biological Products Major Business
Table 20. Wuhan Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product and Services
Table 21. Wuhan Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Wuhan Institute of Biological Products Recent Developments/Updates
Table 23. Lanzhou Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 24. Lanzhou Institute of Biological Products Major Business
Table 25. Lanzhou Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product and Services
Table 26. Lanzhou Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Lanzhou Institute of Biological Products Recent Developments/Updates
Table 28. Beijing Temple of Heaven Biological Products Basic Information, Manufacturing Base and Competitors
Table 29. Beijing Temple of Heaven Biological Products Major Business
Table 30. Beijing Temple of Heaven Biological Products Live Attenuated Japanese Encephalitis Vaccine Product and Services
Table 31. Beijing Temple of Heaven Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Beijing Temple of Heaven Biological Products Recent Developments/Updates
Table 33. Valneva Basic Information, Manufacturing Base and Competitors
Table 34. Valneva Major Business
Table 35. Valneva Live Attenuated Japanese Encephalitis Vaccine Product and Services
Table 36. Valneva Live Attenuated Japanese Encephalitis Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Valneva Recent Developments/Updates
Table 38. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 39. Bharat Biotech Major Business
Table 40. Bharat Biotech Live Attenuated Japanese Encephalitis Vaccine Product and Services
Table 41. Bharat Biotech Live Attenuated Japanese Encephalitis Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Bharat Biotech Recent Developments/Updates
Table 43. Cheng Da Biology Basic Information, Manufacturing Base and Competitors
Table 44. Cheng Da Biology Major Business
Table 45. Cheng Da Biology Live Attenuated Japanese Encephalitis Vaccine Product and Services
Table 46. Cheng Da Biology Live Attenuated Japanese Encephalitis Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Cheng Da Biology Recent Developments/Updates
Table 48. Biocelect Pty Ltd Basic Information, Manufacturing Base and Competitors
Table 49. Biocelect Pty Ltd Major Business
Table 50. Biocelect Pty Ltd Live Attenuated Japanese Encephalitis Vaccine Product and Services
Table 51. Biocelect Pty Ltd Live Attenuated Japanese Encephalitis Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Biocelect Pty Ltd Recent Developments/Updates
Table 53. Glovax Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 54. Glovax Co., Ltd. Major Business
Table 55. Glovax Co., Ltd. Live Attenuated Japanese Encephalitis Vaccine Product and Services
Table 56. Glovax Co., Ltd. Live Attenuated Japanese Encephalitis Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Glovax Co., Ltd. Recent Developments/Updates
Table 58. Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 59. Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global Live Attenuated Japanese Encephalitis Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 61. Market Position of Manufacturers in Live Attenuated Japanese Encephalitis Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and Live Attenuated Japanese Encephalitis Vaccine Production Site of Key Manufacturer
Table 63. Live Attenuated Japanese Encephalitis Vaccine Market: Company Product Type Footprint
Table 64. Live Attenuated Japanese Encephalitis Vaccine Market: Company Product Application Footprint
Table 65. Live Attenuated Japanese Encephalitis Vaccine New Market Entrants and Barriers to Market Entry
Table 66. Live Attenuated Japanese Encephalitis Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 68. Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 69. Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global Live Attenuated Japanese Encephalitis Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 72. Global Live Attenuated Japanese Encephalitis Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 73. Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global Live Attenuated Japanese Encephalitis Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 78. Global Live Attenuated Japanese Encephalitis Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 79. Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 80. Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 81. Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 82. Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 83. Global Live Attenuated Japanese Encephalitis Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 84. Global Live Attenuated Japanese Encephalitis Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 85. North America Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 86. North America Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 87. North America Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 88. North America Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 89. North America Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 90. North America Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 91. North America Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Europe Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Europe Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 96. Europe Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 97. Europe Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 98. Europe Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 99. Europe Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 102. Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 103. Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 104. Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 105. Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 106. Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 107. Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 110. South America Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 111. South America Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 112. South America Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 113. South America Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 114. South America Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 115. South America Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 118. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 119. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 122. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 123. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 125. Live Attenuated Japanese Encephalitis Vaccine Raw Material
Table 126. Key Manufacturers of Live Attenuated Japanese Encephalitis Vaccine Raw Materials
Table 127. Live Attenuated Japanese Encephalitis Vaccine Typical Distributors
Table 128. Live Attenuated Japanese Encephalitis Vaccine Typical Customers
Table 1. Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Novartis Basic Information, Manufacturing Base and Competitors
Table 4. Novartis Major Business
Table 5. Novartis Live Attenuated Japanese Encephalitis Vaccine Product and Services
Table 6. Novartis Live Attenuated Japanese Encephalitis Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Novartis Recent Developments/Updates
Table 8. Sanofi Basic Information, Manufacturing Base and Competitors
Table 9. Sanofi Major Business
Table 10. Sanofi Live Attenuated Japanese Encephalitis Vaccine Product and Services
Table 11. Sanofi Live Attenuated Japanese Encephalitis Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Sanofi Recent Developments/Updates
Table 13. Chengdu Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 14. Chengdu Institute of Biological Products Major Business
Table 15. Chengdu Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product and Services
Table 16. Chengdu Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Chengdu Institute of Biological Products Recent Developments/Updates
Table 18. Wuhan Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 19. Wuhan Institute of Biological Products Major Business
Table 20. Wuhan Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product and Services
Table 21. Wuhan Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Wuhan Institute of Biological Products Recent Developments/Updates
Table 23. Lanzhou Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 24. Lanzhou Institute of Biological Products Major Business
Table 25. Lanzhou Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product and Services
Table 26. Lanzhou Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Lanzhou Institute of Biological Products Recent Developments/Updates
Table 28. Beijing Temple of Heaven Biological Products Basic Information, Manufacturing Base and Competitors
Table 29. Beijing Temple of Heaven Biological Products Major Business
Table 30. Beijing Temple of Heaven Biological Products Live Attenuated Japanese Encephalitis Vaccine Product and Services
Table 31. Beijing Temple of Heaven Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Beijing Temple of Heaven Biological Products Recent Developments/Updates
Table 33. Valneva Basic Information, Manufacturing Base and Competitors
Table 34. Valneva Major Business
Table 35. Valneva Live Attenuated Japanese Encephalitis Vaccine Product and Services
Table 36. Valneva Live Attenuated Japanese Encephalitis Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Valneva Recent Developments/Updates
Table 38. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 39. Bharat Biotech Major Business
Table 40. Bharat Biotech Live Attenuated Japanese Encephalitis Vaccine Product and Services
Table 41. Bharat Biotech Live Attenuated Japanese Encephalitis Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Bharat Biotech Recent Developments/Updates
Table 43. Cheng Da Biology Basic Information, Manufacturing Base and Competitors
Table 44. Cheng Da Biology Major Business
Table 45. Cheng Da Biology Live Attenuated Japanese Encephalitis Vaccine Product and Services
Table 46. Cheng Da Biology Live Attenuated Japanese Encephalitis Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Cheng Da Biology Recent Developments/Updates
Table 48. Biocelect Pty Ltd Basic Information, Manufacturing Base and Competitors
Table 49. Biocelect Pty Ltd Major Business
Table 50. Biocelect Pty Ltd Live Attenuated Japanese Encephalitis Vaccine Product and Services
Table 51. Biocelect Pty Ltd Live Attenuated Japanese Encephalitis Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Biocelect Pty Ltd Recent Developments/Updates
Table 53. Glovax Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 54. Glovax Co., Ltd. Major Business
Table 55. Glovax Co., Ltd. Live Attenuated Japanese Encephalitis Vaccine Product and Services
Table 56. Glovax Co., Ltd. Live Attenuated Japanese Encephalitis Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Glovax Co., Ltd. Recent Developments/Updates
Table 58. Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 59. Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global Live Attenuated Japanese Encephalitis Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 61. Market Position of Manufacturers in Live Attenuated Japanese Encephalitis Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and Live Attenuated Japanese Encephalitis Vaccine Production Site of Key Manufacturer
Table 63. Live Attenuated Japanese Encephalitis Vaccine Market: Company Product Type Footprint
Table 64. Live Attenuated Japanese Encephalitis Vaccine Market: Company Product Application Footprint
Table 65. Live Attenuated Japanese Encephalitis Vaccine New Market Entrants and Barriers to Market Entry
Table 66. Live Attenuated Japanese Encephalitis Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 68. Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 69. Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global Live Attenuated Japanese Encephalitis Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 72. Global Live Attenuated Japanese Encephalitis Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 73. Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global Live Attenuated Japanese Encephalitis Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 78. Global Live Attenuated Japanese Encephalitis Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 79. Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 80. Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 81. Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 82. Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 83. Global Live Attenuated Japanese Encephalitis Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 84. Global Live Attenuated Japanese Encephalitis Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 85. North America Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 86. North America Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 87. North America Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 88. North America Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 89. North America Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 90. North America Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 91. North America Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Europe Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Europe Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 96. Europe Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 97. Europe Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 98. Europe Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 99. Europe Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 102. Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 103. Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 104. Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 105. Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 106. Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 107. Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 110. South America Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 111. South America Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 112. South America Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 113. South America Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 114. South America Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 115. South America Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 118. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 119. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 122. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 123. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 125. Live Attenuated Japanese Encephalitis Vaccine Raw Material
Table 126. Key Manufacturers of Live Attenuated Japanese Encephalitis Vaccine Raw Materials
Table 127. Live Attenuated Japanese Encephalitis Vaccine Typical Distributors
Table 128. Live Attenuated Japanese Encephalitis Vaccine Typical Customers
LIST OF FIGURES
Figure 1. Live Attenuated Japanese Encephalitis Vaccine Picture
Figure 2. Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value Market Share by Type in 2022
Figure 4. 0.5ml Examples
Figure 5. 1ml Examples
Figure 6. 2.5ml Examples
Figure 7. Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value Market Share by Application in 2022
Figure 9. Hospital Examples
Figure 10. Clinic Examples
Figure 11. Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Live Attenuated Japanese Encephalitis Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Live Attenuated Japanese Encephalitis Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Live Attenuated Japanese Encephalitis Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Live Attenuated Japanese Encephalitis Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Live Attenuated Japanese Encephalitis Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Live Attenuated Japanese Encephalitis Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Live Attenuated Japanese Encephalitis Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Live Attenuated Japanese Encephalitis Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Live Attenuated Japanese Encephalitis Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Live Attenuated Japanese Encephalitis Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Live Attenuated Japanese Encephalitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Live Attenuated Japanese Encephalitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Live Attenuated Japanese Encephalitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Live Attenuated Japanese Encephalitis Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Live Attenuated Japanese Encephalitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Live Attenuated Japanese Encephalitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Live Attenuated Japanese Encephalitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Live Attenuated Japanese Encephalitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Live Attenuated Japanese Encephalitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 53. China Live Attenuated Japanese Encephalitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Live Attenuated Japanese Encephalitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Live Attenuated Japanese Encephalitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Live Attenuated Japanese Encephalitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Live Attenuated Japanese Encephalitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Live Attenuated Japanese Encephalitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Live Attenuated Japanese Encephalitis Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Live Attenuated Japanese Encephalitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Live Attenuated Japanese Encephalitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Live Attenuated Japanese Encephalitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Live Attenuated Japanese Encephalitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Live Attenuated Japanese Encephalitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Live Attenuated Japanese Encephalitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Live Attenuated Japanese Encephalitis Vaccine Market Drivers
Figure 74. Live Attenuated Japanese Encephalitis Vaccine Market Restraints
Figure 75. Live Attenuated Japanese Encephalitis Vaccine Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Live Attenuated Japanese Encephalitis Vaccine in 2022
Figure 78. Manufacturing Process Analysis of Live Attenuated Japanese Encephalitis Vaccine
Figure 79. Live Attenuated Japanese Encephalitis Vaccine Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Figure 1. Live Attenuated Japanese Encephalitis Vaccine Picture
Figure 2. Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value Market Share by Type in 2022
Figure 4. 0.5ml Examples
Figure 5. 1ml Examples
Figure 6. 2.5ml Examples
Figure 7. Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value Market Share by Application in 2022
Figure 9. Hospital Examples
Figure 10. Clinic Examples
Figure 11. Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Live Attenuated Japanese Encephalitis Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Live Attenuated Japanese Encephalitis Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Live Attenuated Japanese Encephalitis Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Live Attenuated Japanese Encephalitis Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Live Attenuated Japanese Encephalitis Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Live Attenuated Japanese Encephalitis Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Live Attenuated Japanese Encephalitis Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Live Attenuated Japanese Encephalitis Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Live Attenuated Japanese Encephalitis Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Live Attenuated Japanese Encephalitis Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Live Attenuated Japanese Encephalitis Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Live Attenuated Japanese Encephalitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Live Attenuated Japanese Encephalitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Live Attenuated Japanese Encephalitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Live Attenuated Japanese Encephalitis Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Live Attenuated Japanese Encephalitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Live Attenuated Japanese Encephalitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Live Attenuated Japanese Encephalitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Live Attenuated Japanese Encephalitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Live Attenuated Japanese Encephalitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 53. China Live Attenuated Japanese Encephalitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Live Attenuated Japanese Encephalitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Live Attenuated Japanese Encephalitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Live Attenuated Japanese Encephalitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Live Attenuated Japanese Encephalitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Live Attenuated Japanese Encephalitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Live Attenuated Japanese Encephalitis Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Live Attenuated Japanese Encephalitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Live Attenuated Japanese Encephalitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Live Attenuated Japanese Encephalitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Live Attenuated Japanese Encephalitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Live Attenuated Japanese Encephalitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Live Attenuated Japanese Encephalitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Live Attenuated Japanese Encephalitis Vaccine Market Drivers
Figure 74. Live Attenuated Japanese Encephalitis Vaccine Market Restraints
Figure 75. Live Attenuated Japanese Encephalitis Vaccine Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Live Attenuated Japanese Encephalitis Vaccine in 2022
Figure 78. Manufacturing Process Analysis of Live Attenuated Japanese Encephalitis Vaccine
Figure 79. Live Attenuated Japanese Encephalitis Vaccine Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
